Acesso livre
Acesso livre

Alergia e Imunologia

O que são as vacinas da Sinopharm e da Sinovac? E quão eficazes elas são? Dois especialistas explicam.

5 Jul, 2021 | 10:16h

Related: What are the Sinopharm and Sinovac vaccines? And how effective are they? Two experts explain – The Conversation


Alemanha emite recomendação quanto à mistura de vacinas contra Covid-19.

5 Jul, 2021 | 10:15h

Germany issues world’s strongest recommendation for mixing Covid-19 vaccines – CNN

Relacionado: [Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system”.


[Preprint] Estudo mostra que misturar vacinas contra Covid traz uma boa resposta imunológica – “O estudo Com-Cov pesquisou a eficácia de 2 doses da vacina da Pfizer, 2 da AstraZeneca e também uma de cada. Todas as combinações funcionaram bem em preparar o sistema imune.”

2 Jul, 2021 | 11:19h

Mixing Covid jabs has good immune response, study finds – BBC

Estudo original (preprint): Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine – SSRN Preprints with the Lancet


[Comunicado de imprensa] Vacina da J&J de dose única gera atividade forte e persistente contra a variante Delta e outras variantes do SARS-CoV-2 altamente prevalentes.

2 Jul, 2021 | 11:16h

Comunicado de imprensa: Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response

Comentário: J&J Covid Shot Neutralizes Delta Variant, Company Says – Bloomberg (poucos artigos gratuitos por mês)


Estudo randomizado | Vacina da Novavax confere 89,7% de proteção contra infecção sintomática por SARS-CoV-2 e 100% de proteção contra hospitalizações ou mortes.

1 Jul, 2021 | 10:25h

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine – New England Journal of Medicine

Entrevista de áudio: Audio Interview: Another New Covid-19 Vaccine – New England Journal of Medicine

Relacionado: Opinion | The mRNA vaccines are extraordinary, but Novavax is even better


Análise | Por quanto tempo dura a imunidade contra Covid-19?

1 Jul, 2021 | 10:19h

How long does covid-19 immunity last? – The BMJ


“Long COVID” ou sequelas pós-agudas da COVID-19 (post-acute sequelae of COVID-19 – PASC): uma visão geral dos fatores biológicos que podem contribuir para a persistência dos sintomas.

30 Jun, 2021 | 10:49h

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms – Frontiers in Microbiology


Série de casos | Miocardite após imunização com vacinas de mRNA contra COVID-19.

30 Jun, 2021 | 10:47h

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military – JAMA Cardiology

Ver também: Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination – JAMA Cardiology

Editoriais: Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines E Temporal Associations Between Immunization With the COVID-19 mRNA Vaccines and Myocarditis: The Vaccine Safety Surveillance System Is Working

Comentário: More Evidence Links Myocarditis to mRNA COVID-19 Vaccines – TCTMD

Relacionado: CDC: mRNA vaccines are likely linked to cases of myocarditis and pericarditis – 1,226 cases of myocarditis or pericarditis have been reported mostly in people under 30.

 

Comentário no Twitter

 


Devo tomar a segunda dose da vacina da AstraZeneca? Sim; ela quase dobra sua proteção contra a variante Delta.

30 Jun, 2021 | 10:41h

Should I get my second AstraZeneca dose? Yes, it almost doubles your protection against Delta – The Conversation

Relacionado: Effectiveness of COVID-19 vaccines against the B.1.617.2 variant – medRxiv


Estudo randomizado fase 1/2 | CoronaVac é bem tolerada, segura e induz forte resposta humoral em crianças e adolescentes de 3 a 17 anos de idade.

29 Jun, 2021 | 09:54h

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial – The Lancet Infectious Diseases

Comentário convidado: COVID-19 vaccines for children younger than 12 years: are we ready? – The Lancet Infectious Diseases

 

Comentário no Twitter

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.